$INDI

Wittmann Michael sold $127K of INDI

Wittmann Michael (Chief Operating Officer) sold 24,734 shares of indie Semiconductor, Inc. (INDI) at $5.13 ($0.13M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wittmann Michael
Published Jun 3, 2026, 10:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INDI
Neutral
medium confidence
Mentioned
$INDI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INDINeutralLow
01

Why it matters

The disclosure updates the record of insider ownership but does not introduce new company performance, guidance, or deal information.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure reduces interpretive weight.

03

What to watch

The sale size is modest relative to typical institutional liquidity; without context on total holdings/sale frequency, signal strength is weak.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed after-hours on 2026-06-03; sale occurred 2026-06-02.

Background

This is a SEC Form 4 insider transaction (officer/direct holdings) for indie Semiconductor, disclosed via EDGAR.

Company-level read

Ticker impact

$INDINeutralMedium confidence
Context

Indie Semiconductor COO Michael Wittmann sold $126,954 of INDI shares via an open-market transaction under a 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and small.

Evidence & confidence

The filing is an ownership-change disclosure with a pre-arranged 10b5-1 plan and no accompanying company-specific operational or financial update.

Market effects

Minimal; this is company-specific insider activity with no stated sector catalyst.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with perceived valuation risk; monitor for follow-on sales or larger-than-usual volume.

Key entities

  • indie Semiconductor, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Wittmann Michael

    Chief Operating Officer who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KRMNMed

OC Aerospace, Tech Companies Report Booming Sales

Karman Holdings (NYSE: KRMN) raised its FY2026 revenue outlook to $730M-$745M after Q2 revenue rose 58% to $182M, beating expectations. The article also summarizes earnings for TTM Technologies (TTMI), Viant Technology (DSP), Ducommun (DCO), Indie Semiconductor (INDI), and Clean Energy Fuels (CLNE), citing revenue and guidance figures.

$INDIMedAI 8/10

Indie Semi Jumps on Revenue Increase

Indie Semiconductor (Nasdaq: INDI) shares rose 16% to $4.00 in after-hours after reporting 24% higher Q2 revenue versus the same period in 2025. For the current quarter, it expects revenue of $67 million to $73 million, implying about 30% YoY growth at the midpoint.

$INDIHigh

indie Semiconductor, Inc. (INDI): Results of Operations and Financial Condition

indie Semiconductor, Inc. (INDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 indie Reports Second Quarter 2026 Results • Delivers Revenue of $64M, up 24% Y-o-Y and exceeds midpoint of the guidance range • Guides for accelerating growth of 30% Y-o-Y in Q3 2026 • Substantially narrows GAAP and Non-GAAP Operating Losses • Gains global OEM adopti

$HIVEMedAI 8/10

Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy

The article says US small-cap and penny stocks are benefiting from AI-driven risk appetite, citing the Russell 2000’s 16% YTD outperformance. It lists “Top 10” penny stocks under $5, using S&P 500 10% YTD outperformance, >20% upside, and hedge-fund holdings. For HIVE (share $4.54), it reports FY2026 revenue $297.8M (+158%) and adjusted EBITDA $72.9M. For indie Semiconductor (share $4.93), Benchmark reiterates Buy and an $8 target after a €40M acquisition of ams OSRAM’s CMOS image sensor business